Common germline-somatic variant interactions in advanced urothelial cancer

Common germline-somatic variant interactions in advanced urothelial cancer

Common germline-somatic variant interactions in advanced urothelial cancer Nature Communications volume 11, Article number: 6195 (2020) Cite this article 27 Altmetric Cancer...

Common germline-somatic variant interactions in advanced urothelial cancer

Common germline-somatic variant interactions in advanced urothelial cancer

Common germline-somatic variant interactions in advanced urothelial cancer Cancer genomics Abstract The prevalence and biological consequences of deleterious germline variants...

Team uses organoid technology and single-cell RNA sequencing to study bladder cancer

Team uses organoid technology and single-cell RNA sequencing to study bladder cancer

Investigation of biological mechanisms in urothelial tissue, one of the three types of tissue that make up the urinary system, has always been very limited due to the lack of...

Urine test shows potential for detection, personalized treatment of bladder cancer

Urine test shows potential for detection, personalized treatment of bladder cancer

Urine test shows potential for detection, personalized treatment of bladder cancer October 16, 2019 Add Topic To Email Alerts Please provide your email address to receive an...

‘Exceptional’ cancer patients yield clues to better drug treatments

‘Exceptional’ cancer patients yield clues to better drug treatments

Although even the best cancer drugs don’t buy much time for most people whose cancer has spread, there are rare exceptions: the patients whose multiple tumors melt away and who...

Non-muscle Invasive Bladder Cancer: Symptoms, Diagnosis & Treatment

Non-muscle Invasive Bladder Cancer: Symptoms, Diagnosis & Treatment

See More  See Less   Blood in the urine is the most common symptom of bladder cancer. It is generally painless. Often, you cannot see blood in your urine without a microscope....

DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1

DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1

cell death & disease Cell signalling Abstract Bladder cancer is one of the most commonly diagnosed malignant tumors in the urinary system and causes a massive cancer-related...

Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers

Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers

Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers Metrics details Abstract Several experimental models including...

Many Older Patients Not Getting Recommended Treatment for Early-Stage Bladder Cancer, Study Finds

Many Older Patients Not Getting Recommended Treatment for Early-Stage Bladder Cancer, Study Finds

The majority of patients diagnosed with bladder cancer have early-stage non-muscle-invasive disease that often can be successfully treated. However, these cancers have a high...

The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness

The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness

Bladder cancer is a highly prevalent disease worldwide and is associated with a high mortality rate. Across all stages of bladder cancer, immunotherapy has now become the...

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity Nature Communications volume 11, Article number: 5549 (2020) Cite this article 10...

Non-muscle Invasive Bladder Cancer:  Overcoming Diagnostic and Therapeutic Challenges

Non-muscle Invasive Bladder Cancer: Overcoming Diagnostic and Therapeutic Challenges

TURBT is central to NMIBC diagnosis and treatment. Current guidelines from the AUA/Society of Urologic Oncology (SUO) and the EAU use risk stratification to guide additional...